T57
N-{6-[(4-fluorobenzoyl)amino]hexanoyl}-L-gamma-glutamyl-5-{[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]oxy}-L-norvaline
Find entries where: T57
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | N-{6-[(4-fluorobenzoyl)amino]hexanoyl}-L-gamma-glutamyl-5-{[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]oxy}-L-norvaline |
Identifiers | (2S)-2-[[[(4S)-4-[[(4S)-4-[6-[(4-fluorophenyl)carbonylamino]hexanoylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentoxy]-oxidanyl-phosphoryl]amino]pentanedioic acid |
Formula | C28 H40 F N4 O14 P |
Molecular Weight | 706.608 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc(ccc1C(=O)NCCCCCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCOP(=O)(N[C@@H](CCC(=O)O)C(=O)O)O)C(=O)O)C(=O)O)F |
InChI | InChI=1S/C28H40FN4O14P/c29-18-9-7-17(8-10-18)25(38)30-15-3-1-2-6-22(34)32-20(27(41)42)11-13-23(35)31-19(26(39)40)5-4-16-47-48(45,46)33-21(28(43)44)12-14-24(36)37/h7-10,19-21H,1-6,11-16H2,(H,30,38)(H,31,35)(H,32,34)(H,36,37)(H,39,40)(H,41,42)(H,43,44)(H2,33,45,46)/t19-,20-,21-/m0/s1 |
InChIKey | IZLOSIXADNUSCM-ACRUOGEOSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 88 |
Chiral Atom Count | 3 |
Bond Count | 88 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB14965 |
---|---|
Name | CTT-1057 |
Groups | investigational |
Description | CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma). |
Synonyms | CTT-1057 |
CAS number | 1628717-55-4 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3427435 |
PubChem | 73386645 |
ChEMBL | CHEMBL3427435 |